Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 07, 2018

SELL
$46.25 - $104.45 $380,360 - $858,996
-8,224 Closed
0 $0
Q1 2018

May 01, 2018

BUY
$57.4 - $108.44 $472,057 - $891,810
8,224 New
8,224 $874,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $238M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Highland Private Wealth Management Portfolio

Follow Highland Private Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Private Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Highland Private Wealth Management with notifications on news.